The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tereshchenko N.M.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

Krasnov V.S.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

Totolian N.A.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

Verbitskaya E.V.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

Amelin A.V.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

Clinico-demographic characteristics and immunological cerebrospinal fluid markers in patients with headache and multiple sclerosis

Authors:

Tereshchenko N.M., Krasnov V.S., Totolian N.A., Verbitskaya E.V., Amelin A.V.

More about the authors

Journal: Russian Journal of Pain. 2026;24(1): 5‑11

Read: 560 times


To cite this article:

Tereshchenko NM, Krasnov VS, Totolian NA, Verbitskaya EV, Amelin AV. Clinico-demographic characteristics and immunological cerebrospinal fluid markers in patients with headache and multiple sclerosis. Russian Journal of Pain. 2026;24(1):5‑11. (In Russ.)
https://doi.org/10.17116/pain2026240115

Recommended articles:
Mole­cular mechanisms of acute disseminated ence­phalomyelitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):7-11
The role of mono­cytes in the immu­nopathogenesis of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):23-27
Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple scle­rosis). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):34-38
Features of the clinical course of multiple scle­rosis as a factor in persistent disa­bility. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):39-44
Quantitative analysis of cere­brospinal fluid flow in multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):45-50
Resu­lts of 4 years of therapy with divo­zilimab in patients with rela­psing multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):51-59

References:

  1. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162-173.  https://doi.org/10.1016/S1474-4422(17)30470-2
  2. Wang L, Zhang J, Deng ZR, Zu MD, Wang Y. The epidemiology of primary headaches in patients with multiple sclerosis. Brain Behav. 2021 Jan; 11(1):e01830. https://doi.org/10.1002/brb3.1830
  3. Gklinos P, Mitsikostas D-D. Headache disorders in multiple sclerosis: Is there an association? A systematic review and meta-analysis. Mult Scler Relat Disord. 2024 May;85:105536. https://doi.org/10.1016/j.msard.2024.105536
  4. Mirmosayyeb O, Barzegar M, Nehzat N, Shaygannejad V, Sahraian MA, Ghajarzadeh M. The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis. J Clin Neurosci. 2020 Sept;79:33-38.  https://doi.org/10.1016/j.jocn.2020.06.021
  5. Fragoso YD, Adoni T, Alves-Leon SV, Apostolos-Pereira SL, Carneiro MAD, Chikota EM, Diniz DS, Eboni ACB, Gomes S, Gonçalves MVM, Goncalves RP, Inojosa JL, Junqueira TF, Machado SC, Malfetano FR, Mansur LF, Mendes MF, Muniz A, Nobrega Junior AW, Olival GSD, Parolin MF, Pimentel MLV, Rocha CF, Ruocco HH, Santos GC, Siquineli F, Soares JOD, Sousa NAC, Tauil CB, Winckler TCA. Migraine in 746 patients with multiple sclerosis. Arq Neuropsiquiatr. 2019 Sept 23;77(9):617-621.  https://doi.org/10.1590/0004-282X20190100
  6. Rościszewska-Żukowska I, Galiniak S, Bartosik-Psujek H. Clinical Characteristics of Headache in Multiple Sclerosis Patients: A Cross-Sectional Study. J Clin Med. 2023 May 17;12(10):3518. https://doi.org/10.3390/jcm12103518
  7. Makshakov GS, Lapin SV, Evdoshenko EP. Current concepts on intrathecal humoral immune response and diagnostic importance of oligoclonal immunoglobulins in multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. Special Issues. 2016;116(2-2):14-20. (In Russ.). https://doi.org/10.17116/jnevro20161162214-20
  8. Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):909-14.  https://doi.org/10.1136/jnnp-2012-304695
  9. Skov AG, Skov T, Frederiksen JL. Oligoclonal bands predict multiple sclerosis after optic neuritis: a literature survey. Mult Scler. 2011 Apr;17(4):404-410.  https://doi.org/10.1177/1352458510391340
  10. Bourahoui A, De Seze J, Guttierez R, Onraed B, Hennache B, Ferriby D, Stojkovic T, Vermersch P. CSF isoelectrofocusing in a large cohort of MS and other neurological diseases. Eur J Neurol. 2004 Aug;11(8):525-9.  https://doi.org/10.1111/j.1468-1331.2004.00822.x
  11. Hegen H, Berek K, Cavalla P, Christiansen M, Emeršič A, Di Filippo M, Gaetani L, Hassler M, Leurs C, Milosavljevic D, van Pesch V, Petersen T, Presslauer S, Rosenstein I, Rot U, Schnabl C, Teunissen C, Vecchio D, Vercellino M, Deisenhammer F. Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis — a multicentre study. Front Immunol. 2023 Dec 19;14:1327947. https://doi.org/10.3389/fimmu.2023.1327947
  12. Desplat-Jégo S, Feuillet L, Pelletier J, Bernard D, Chérif AA, Boucraut J. Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry. J Clin Immunol. 2005 July;25(4):338-345.  https://doi.org/10.1007/s10875-005-5371-9
  13. Senel M, Tumani H, Lauda F, Presslauer S, Mojib-Yezdani R, Otto M, Brettschneider J. Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis. PLoS One. 2014 Apr 02; 9(4):e88680. https://doi.org/10.1371/journal.pone.0088680
  14. Makshakov G, Nazarov V, Kochetova O, Surkova E, Lapin S, Evdoshenko E. Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis. PLoS One. 2015 Nov 25;10(11):e0143375. https://doi.org/10.1371/journal.pone.0143375
  15. Gebhardt M, Kropp P, Jürgens TP, Hoffmann F, Zettl UK. Headache in the first manifestation of Multiple Sclerosis — Prospective, multicenter study. Brain Behav. 2017 Nov 16;7(12):e00852. https://doi.org/10.1002/brb3.852
  16. Loma I, Heyman R. Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol. 2011 Sept;9(3):409-416.  https://doi.org/10.2174/157015911796557911
  17. Makshakov GS, Nazarov VD, Totolian NA, et al. The association of intrathecal production of immunoglobulin free light chains and progression of multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. Special Issues. 2017;117(10-2):4-10. (In Russ.). https://doi.org/10.17116/jnevro20171171024-10
  18. Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017 Apr;97(2):553-622.  https://doi.org/10.1152/physrev.00034.2015

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.